FDA awards funding to Perspectum and physicians at Massachusetts General Hospital to accelerate development of imaging biomarkers as drug development tools in liver disease
December 14, 2020
Perspectum’s RADIcAL1 trial - addressing the health economic burden of invasive diagnostics for NAFLD and NASH
December 9, 2020
Post-conference Q&A - AASLD: The Digital Liver Meeting Experience
December 2, 2020
Hepatica – new tool informs surgeons about previously undiagnosed background liver disease, helping to improve surgical decision-making in liver cancer care
Perspectum presents new data, addressing key challenges of smart imaging
November 29, 2020
Reversing fatty liver disease; New study in Hong Kong will use state-of-the-art clinical technology to evaluate different weight-loss methods
November 17, 2020
CHRISTUS Shreveport-Bossier Health System and Perspectum Offer New Insights into Liver Health with LiverMultiScan
Perspectum launches new multiorgan imaging offering, Atlas®, for pharma sponsors at The Liver Meeting Digital Experience™ (TLMdX) 2020
November 10, 2020
Perspectum Releases New Whitepaper on The Cost-Effectiveness of Including Imaging in Phase 3 NASH Trials
October 20, 2020